Allergen received FDA approval late last month for its pinkeye treatment, Zymar, and plans to have the drug in pharmacies by the end of the month.
Zymar is the first fourth-generation fluoroquinilone to enter the market.
COPYRIGHT 2003 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2003 Gale Group